Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP194582.RAgXLig6_HRlIdRF-eWC7dg35Nj8RJylMZ3bb2GuaXvYg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP194582.RAgXLig6_HRlIdRF-eWC7dg35Nj8RJylMZ3bb2GuaXvYg130_assertion type Assertion NP194582.RAgXLig6_HRlIdRF-eWC7dg35Nj8RJylMZ3bb2GuaXvYg130_head.
- NP194582.RAgXLig6_HRlIdRF-eWC7dg35Nj8RJylMZ3bb2GuaXvYg130_assertion description "[ALK translocations were found in 4/151 (2.6%; 3 of them involving EML4) of BM of adenocarcinomas (AC), 1/9 (11.1%) of adenosquamous carcinomas (ASC), 0/5 of squamous cell carcinomas (SCC) and 0/10 of large cell carcinomas (LCC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP194582.RAgXLig6_HRlIdRF-eWC7dg35Nj8RJylMZ3bb2GuaXvYg130_provenance.
- NP194582.RAgXLig6_HRlIdRF-eWC7dg35Nj8RJylMZ3bb2GuaXvYg130_assertion evidence source_evidence_literature NP194582.RAgXLig6_HRlIdRF-eWC7dg35Nj8RJylMZ3bb2GuaXvYg130_provenance.
- NP194582.RAgXLig6_HRlIdRF-eWC7dg35Nj8RJylMZ3bb2GuaXvYg130_assertion SIO_000772 23453647 NP194582.RAgXLig6_HRlIdRF-eWC7dg35Nj8RJylMZ3bb2GuaXvYg130_provenance.
- NP194582.RAgXLig6_HRlIdRF-eWC7dg35Nj8RJylMZ3bb2GuaXvYg130_assertion wasDerivedFrom befree-20140225 NP194582.RAgXLig6_HRlIdRF-eWC7dg35Nj8RJylMZ3bb2GuaXvYg130_provenance.
- NP194582.RAgXLig6_HRlIdRF-eWC7dg35Nj8RJylMZ3bb2GuaXvYg130_assertion wasGeneratedBy ECO_0000203 NP194582.RAgXLig6_HRlIdRF-eWC7dg35Nj8RJylMZ3bb2GuaXvYg130_provenance.